Market Place
Sourcing Support
Evoke Pharma & Eversana Improvement in Gastroparesis Outcomes
28 Oct 2024 //
GLOBENEWSWIRE
Evoke Announces Appointment of Ben to Board of Directors
22 Oct 2024 //
GLOBENEWSWIRE
Evoke Pharma Reaffirms Commitment To Gastroparesis Patients
19 Sep 2024 //
GLOBENEWSWIRE
Avenacy Launches Metoclopramide Injection In U.S. Market
16 Sep 2024 //
BUSINESSWIRE
Evoke Pharma To Participate In GHAPP Annual Conference
09 Sep 2024 //
GLOBENEWSWIRE
Evoke Pharma To Present At H.C. Wainwright Conference
04 Sep 2024 //
GLOBENEWSWIRE
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
13 Aug 2024 //
GLOBENEWSWIRE
Teva`s Generic Metoclopramide Receives Approval in the U.S.
08 Mar 2024 //
FDA
Evoke Pharma receives US patent for Gimoti nasal spray
02 Dec 2022 //
PHARMABIZ
Enforcement Report - Week of August 25, 2021
25 Aug 2021 //
FDA
Evoke Pharma to receive US patent for Gimoti nasal spray
09 Jun 2021 //
PHARMABIZ
Enforcement Report - Week of March 10, 2021
10 Mar 2021 //
FDA
Evoke Pharma finally lands approval for lead and only drug
22 Jun 2020 //
ENDPTS
Evoke Pharma finally lands approval for lead and only drug
22 Jun 2020 //
ENDPTS
FDA flags device dosing in rejecting Evoke`s Gimoti nasal spray
03 Apr 2019 //
FIERCE BIOTECH
Vanda’s PhII data offer hope for gastroparesis patients
03 Dec 2018 //
ENDPTS
Evoke’s experience with Thermo wins Patheon nasal metoclopramide contract
13 Nov 2017 //
IN PHARMATECHNOLOGIST
EndoLogic Acquires Renzapride from Alizyme, plc
03 Jan 2017 //
GLOBENEWSWIRE
Evoke Receives Positive NDA Submission Guidance from US FDA for Gimoti
15 Dec 2016 //
GLOBENEWSWIRE
Rusan Pharma Ltd fails EDQM Inspection
04 Apr 2016 //
EDQM
India`s Wockhardt Faces Mass Of Lawsuits In U.S. Over Generic Reglan
26 Mar 2015 //
FIERCE PHARMA ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.